60736-79-0

Basic information

• Product Name: 1-(chloromethyl)-4-(2-methylpropyl)benzene
• CAS NO: 60736-79-0
• Molecular Formula: C₁₁H₁₅Cl
• Molecular Weight: 182.6898
• Mol File: 60736-79-0.mol

Chemical Properties

• Boiling Point: 248.9°C at 760 mmHg
• Flash Point: 98.4°C
• Density: 0.996g/cm³
• Vapor Pressure: 0.0372mmHg at 25°C
• Refractive Index: 1.509
• CAS DataBase Reference: 1-(chloromethyl)-4-(2-methylpropyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(chloromethyl)-4-(2-methylpropyl)benzene(60736-79-0)
• EPA Substance Registry System: 1-(chloromethyl)-4-(2-methylpropyl)benzene(60736-79-0)

Safety Data

• Hazardous Substances Data: 60736-79-0(Hazardous Substances Data)

Usage

Structure

A benzene ring with a chloromethyl group at the 1 position and a 2-methylpropyl group at the 4 position

Usage

a. Precursor in the synthesis of various organic compounds
b. Intermediate in the production of pharmaceuticals, agrochemicals, and specialty chemicals

Physical state

Flammable liquid

Odor

Slightly sweet

Health risks

Inhalation, ingestion, or skin contact can pose health risks

Safety precautions

Proper handling and safety measures are necessary when working with 1-(chloromethyl)-4-(2-methylpropyl)benzene

Upstream product

• 50-00-0 formaldehyd 
• 538-93-2 1-phenyl-2-methylpropane 

Downstream Products

• 40784-95-0 2-(4-isobutylphenyl)propionitrile 
• 36458-20-5 C,C,C-Trifluoro-N-(4-isobutyl-benzyl)-methanesulfonamide 
• 139154-76-0 ethyl 4-[3-[3,5-bis[N-(4-isobutylbenzyl)-N-tert-butoxycarbonyl-amino]benzoyl]indol-1-yl]butyrate 
• 148255-44-1 phenyl 4-(4-isobutylbenzyloxy)benzoate 
• 225942-80-3 phenyl 3-<4-(2-methyl-2-propenyl)phenoxymethyl>benzoate 
• 120011-21-4 4-(4-isobutylbenzyloxy)benzoic acid 
• 148255-13-4 methyl 4-(4-isobutylbenzyloxy)benzoate 
• 1553-60-2 ibufenac 
• 60736-82-5 3-chloro-4-(4'-isobutylbenzyloxy)-phenylacetic acid 

Relevant articles and documents

FUNGAL CELL WALL SYNTHESIS GENE

A reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered. Further, genes conferring resistance to the above compounds were identified and methods of screening for compounds that inhibit the activity of the proteins encoded by these genes were developed.Therefore, through the novel compounds, the present invention showed that antifungal agents having a novel mechanism, i.e. inhibiting the process that transports GPI-anchored proteins to the cell wall, could be achieved.

Phenylalkanoic compounds and therapeutic use thereof

Novel phenylalkanoic compounds of the formula I STR1 wherein R1 and R2 independently from each other represent hydrogen or alkyl with 1 to 8 carbon atoms, salts of such compounds and salts thereof, therapeutic uses of the phenylalkanoic compounds, or of the pharmacologically safe salts thereof for treating inflammatory diseases, tussive states, pain symptoms and pyretic diseases and pharmaceutical composition containing the phenylalkanoic compounds or the pharmacologically safe salts together with a carrier and an optional adjuvant or additive.